Green Thumb Industries Earnings Preview: Can the Cannabis Industry’s Most Consistent Cash Generator Deliver Again?

Green Thumb Industries reports second-quarter 2026 earnings after the market closes today, with investors looking to see whether one of the cannabis industry’s strongest financial performers can extend its streak of profitable growth.

As one of the few large U.S. multistate operators consistently generating positive net income, robust cash flow and industry-leading margins, Green Thumb’s results often set the tone for investor sentiment across the sector.

Grown Rogue is also scheduled to release quarterly results after the close.

Green Thumb Industries Earnings Preview

Green Thumb’s Last Earnings Report

Green Thumb entered today’s earnings release with considerable momentum. In the first quarter of 2026, the company generated $300.2 million in revenue, up 7.4% year over year, continuing its track record of steady top-line growth despite ongoing pricing pressure across several mature cannabis markets.

The company’s profitability remained among the strongest in the U.S. cannabis industry. Gross profit totaled approximately $144 million, representing a 47.9% gross margin, while Normalized Adjusted EBITDA reached $93.5 million, or 31.2% of revenue, highlighting Green Thumb’s ability to preserve margins even in a challenging operating environment.

Cash generation continued to distinguish Green Thumb from many of its peers. The company produced $76.0 million in operating cash flow, generated roughly $57 million in free cash flow after capital expenditures, and ended the quarter with $344.5 million in cash. It also repurchased approximately 6 million shares for $33.3 million, later expanding buybacks to roughly 13.4 million shares for $77.7 million following quarter-end.

Green Thumb also reported GAAP net income of $15.4 million, extending one of the industry’s longest streaks of positive earnings among major U.S. operators.

What Management Said

Management said the company’s disciplined capital allocation strategy remains unchanged, emphasizing continued cash generation, opportunistic share repurchases, selective expansion opportunities, and long-term confidence following the federal rescheduling of medical cannabis to Schedule III.

Executives also highlighted leadership positions in Illinois, Pennsylvania, Maryland, Ohio, and Minnesota while announcing applications for DEA registration for certain medical cannabis operations.

What To Watch In Today’s Earnings

Investors should focus on whether Green Thumb can maintain its industry-leading profitability while continuing to grow revenue. Key metrics include gross margin, Adjusted EBITDA margin, operating cash flow, free cash flow and cash on the balance sheet.

Commentary surrounding Ohio’s adult-use rollout, Minnesota, the newly awarded Texas medical license, capital allocation, additional share repurchases, M&A opportunities and the practical implications of Schedule III will likely receive equal attention from investors.

Grown Rogue Earnings Preview

Grown Rogue’s Last Earnings Report

• Grown Rogue reported first-quarter revenue of $9.2 million, up approximately 28% year over year, while raising its full-year revenue guidance as continued strength in New Jersey and cultivation efficiency supported growth.

What Management Said

• Management highlighted improving yields, expanding product offerings, disciplined execution, and progress entering Illinois and Minnesota as the company’s next growth markets.

What To Watch In Today’s Earnings

• Investors will primarily watch whether New Jersey continues driving growth, whether margins remain strong as expansion continues, and whether management updates revenue guidance or timelines for Illinois and Minnesota.

Why Today’s Earnings Matter

Today’s reports offer investors a snapshot of two companies executing very different strategies. Green Thumb continues to set the benchmark among large U.S. cannabis operators for profitability, free cash flow and disciplined capital allocation, while Grown Rogue has built its business through cultivation efficiency and measured expansion in limited-license markets. Together, their results should provide another important read on whether the industry’s strongest operators continue separating themselves from the broader sector.

For investors, executives and operators looking to better understand the trends shaping cannabis finance, capital markets and federal policy, many of these same topics will be front and center at IgniteIt’s Capital & Policy Summit on November 18 in Washington, D.C. The event will bring together leading cannabis executives, investors, policymakers and capital markets professionals for discussions on rescheduling, banking, hemp policy, M&A, capital formation and the industry’s next phase of growth.

Learn more and register: IgniteIt Capital & Policy Summit – Washington, D.C.